Cancer stem cells (CSCs) constitute a minor population of cancer cells with the capacity to self-renew, differentiate, and promote cancer development. The session "Cancer Stem Cells" is dedicated to comprehending their function in tumor development, metastasis, and drug resistance.".
CSCs are frequently refractory to traditional therapy like chemotherapy and radiotherapy, which can kill bulk tumor cells but spare the CSCs, resulting in relapse and disease progression. An understanding of the biology of these cells is essential for the design of approaches that address the tumor mass and its origins. The key mechanisms are signaling pathways, epigenetic regulation, and interactions with the tumor microenvironment that facilitate CSC survival and growth.
This session examines new therapeutic strategies to eradicate CSCs, such as targeted therapy, immunotherapy, and combination therapy. The improvements in the molecular profiling and biomarker discovery assist clinicians in detecting and tracking the CSC populations and thereby better interventions and personalization.
Participants will learn about CSC biology, clinical relevance, and novel approaches to targeting these hardy cells. This session highlights the need to target cancer stem cells to forestall recurrence, enhance therapeutic outcomes, and speed development of long-lasting, long-term cancer treatments.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
